Scientists’ New Goal: Growing Old Without Disease
Wall Street Journal
By SUMATHI REDDY
March 16, 2015 5:43 p.m. ET
Nir Barzilai, director of the Institute for Aging Research at Albert
Einstein College of Medicine in New York City is heading the
Targeting/Taming Aging With Metformin (TAME) study.
Jill Crandall, director of the Diabetes Clinical Trials Unit at Albert
Einstein College of Medicine is part of the TAME planning team.
Metformin isn’t necessarily more promising than other drugs that have shown
signs of extending life and reducing age-related chronic diseases. But
metformin has been widely and safely used for more than 60 years, has very
few side effects and is inexpensive.
Note from Johnny: I’ve been on metformin since my age management physician
Dr. Lee-Benner (www.TheAntiAgingDoctor.com) first prescribed it about 9 years ago. It’s an aging intervention — NOT for diabetes.
Link to article:
John M. “Johnny” Adams
Executive Director Gerontology Research Group
(949) 922-9786 cell
CEO / Exec. Director
Carl I. Bourhenne Medical Research Foundation / Aging Intervention